MicroRNA abundance is altered in synaptoneurosomes during prion disease

Molecular and Cellular Neuroscience

Volumn 71, Issue , 2016, Pages 13-24

  Boese, Amrit S ^a,d   Saba, Reuben ^a   Campbell, Kristyn ^a,d   Majer, Anna ^a,d   Medina, Sarah ^a   Burton, Lynn ^b   Booth, Timothy F ^a   Chong, Patrick ^a   Westmacott, Garrett ^a   Dutta, Sucharita M ^c   Saba, Julian A ^c   Booth, Stephanie A ^a,d  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b CANADIAN FOOD INSPECTION AGENCY   (Canada)

^c Thermo Fisher Scientific   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Dendrite; MiRNA; Neurodegeneration; Prion disease; Synapse; Synaptoneurosome

Indexed keywords

MICRORNA; MICRORNA 124A 3P; MICRORNA 136 5P; MICRORNA 141 3P; MICRORNA 142 3P; MICRORNA 143 3P; MICRORNA 145A 5P; MICRORNA 146A 5P; MICRORNA 150 5P; MICRORNA 182 5P; MICRORNA 183 5P; MICRORNA 200A 3P; MICRORNA 200B 3P; MICRORNA 200C 3P; MICRORNA 320; MICRORNA 376A 3P; MICRORNA 429 3P; MICRORNA 451A; MICRORNA LET 7B; UNCLASSIFIED DRUG; PRION;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DENDRITE; FOREBRAIN; GENETIC REGULATION; GLIA CELL; MOUSE; NERVE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; RNA ANALYSIS; SYNAPTONEUROSOME; ANIMAL; GENETICS; HIPPOCAMPUS; METABOLISM; PATHOLOGY; PRION; SYNAPSE;

ANIMALS; DENDRITES; HIPPOCAMPUS; MICE; MICRORNAS; PRION DISEASES; PRIONS; SYNAPSES;

EID: 84949845696     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2015.12.001     Document Type: Article

References (61)

1. Arvanitis D.N., Jungas T., Behar A., Davy A. Ephrin-B1 reverse signaling controls a posttranscriptional feedback mechanism via miR-124. Mol. Cell. Biol. 2010, 30(10):2508-2517.
2. Bail S., et al. Differential regulation of microRNA stability. RNA 2010, 16(5):1032-1039.
3. Butovsky O., et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat. Neurosci. 2014, 17(1):131-143.
4. Campeau J.L., Wu G., Bell J.R., Rasmussen J., Sim V.L. Early increase and late decrease of Purkinje cell dendritic spine density in prion-infected organotypic mouse cerebellar cultures. PLoS One 2013, 8(12):e81776.
5. Chaudhuri A.D., Yelamanchili S.V., Fox H.S. MicroRNA-142 reduces monoamine oxidase A expression and activity in neuronal cells by downregulating SIRT1. PLoS One 2013, 8(11):e79579.
6. Chen Y.L., Shen C.K. Modulation of mGluR-dependent MAP1B translation and AMPA receptor endocytosis by microRNA miR-146a-5p. J. Neurosci. 2013, 33(21):9013-9020.
7. Clinton J., Forsyth C., Royston M.C., Roberts G.W. Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. Neuroreport 1993, 4(1):65-68.
8. Cohen J.E., Lee P.R., Chen S., Li W., Fields R.D. MicroRNA regulation of homeostatic synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(28):11650-11655.
9. Distler U., et al. In-depth protein profiling of the postsynaptic density from mouse hippocampus using data-independent acquisition proteomics. Proteomics 2014, 14(21-22):2607-2613.
10. Doyle M., Kiebler M.A. Mechanisms of dendritic mRNA transport and its role in synaptic tagging. EMBO J. 2011, 30(17):3540-3552.
11. Fiore R., et al. MiR-134-dependent regulation of pumilio-2 is necessary for homeostatic synaptic depression. EMBO J. 2014, 33(19):2231-2246.
12. Gandhi R., et al. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann. Neurol. 2013, 73(6):729-740.
13. Garza-Manero S., Pichardo-Casas I., Arias C., Vaca L., Zepeda A. Selective distribution and dynamic modulation of miRNAs in the synapse and its possible role in Alzheimer's disease. Brain Res. 2014, 1584:80-93.
14. Gu X., et al. miR-124 represses ROCK1 expression to promote neurite elongation through activation of the PI3K/akt signal pathway. J. Mol. Neurosci. 2014, 52(1):156-165.
15. Iyer A., et al. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One 2012, 7(9):e44789.
16. Jensen S.G., et al. Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics 2011, 12:435.
17. Joilin G., et al. Rapid regulation of microRNA following induction of long-term potentiation in vivo. Front. Mol. Neurosci. 2014, 7:98.
18. Khosravani H., et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Cell Biol. 2008, 181(3):551-565.
19. Kitamoto T., et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am. J. Pathol. 1992, 140(6):1285-1294.
20. Kohen R., Dobra A., Tracy J.H., Haugen E. Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illness. Transl. Psychiatry 2014, 4:e366.
21. Kumar M., Nerurkar V.R. Integrated analysis of microRNAs and their disease related targets in the brain of mice infected with west Nile virus. Virology 2014, 452-453:143-151.
22. Lee S.T., et al. MicroRNAs induced during ischemic preconditioning. Stroke 2010, 41(8):1646-1651.
23. Lee Y.J., Johnson K.R., Hallenbeck J.M. Global protein conjugation by ubiquitin-like-modifiers during ischemic stress is regulated by microRNAs and confers robust tolerance to ischemia. PLoS One 2012, 7(10):e47787.
24. Li H., Wu C., Aramayo R., Sachs M.S., Harlow M.L. Synaptic vesicles contain small ribonucleic acids (sRNAs) including transfer RNA fragments (trfRNA) and microRNAs (miRNA). Sci. Rep. 2015, 5:14918.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25(4):402-408.
26. Lugli G., Torvik V.I., Larson J., Smalheiser N.R. Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain. J. Neurochem. 2008, 106(2):650-661.
27. Lugli G., Larson J., Demars M.P., Smalheiser N.R. Primary microRNA precursor transcripts are localized at post-synaptic densities in adult mouse forebrain. J. Neurochem. 2012, 123(4):459-466.
28. Lukiw W.J., Dua P., Pogue A.I., Eicken C., Hill J.M. Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome. J. Toxicol. Environ. Health A 2011, 74(22-24):1460-1468.
29. Magill S.T., et al. MicroRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(47):20382-20387.
30. Maiorano N.A., Mallamaci A. Promotion of embryonic cortico-cerebral neuronogenesis by miR-124. Neural Dev. 2009, 4:40.
31. Majer A., et al. Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog. 2012, 8(11):e1003002.
32. Mallucci G.R., et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 2007, 53(3):325-335.
33. Mestdagh P., et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009, 10(6):R64.
34. Montag J., et al. Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. Mol. Neurodegener. 2009, 4:36.
35. Montag J., et al. A genome-wide survey for prion-regulated miRNAs associated with cholesterol homeostasis. BMC Genomics 2012, 13:486.
36. Moreno J.A., et al. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med. 2013, 5(206):206ra138.
37. Most D., Leiter C., Blednov Y.A., Harris R.A., Mayfield R.D. Synaptic microRNAs coordinately regulate synaptic mRNAs: perturbation by chronic alcohol consumption. Neuropsychopharmacology 2016, 41:538-548. (published online 5 August 2015). 10.1038/npp.2015.179.
38. Muslimov I.A., et al. RNA transport in dendrites: a cis-acting targeting element is contained within neuronal BC1 RNA. J. Neurosci. 1997, 17(12):4722-4733.
39. Noorbakhsh F., et al. MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB J. 2010, 24(6):1799-1812.
40. Paraskevopoulou M.D., et al. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res. 2013, 41(Web Server issue):W169-W173.
41. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(23):13363-13383.
42. Rao A., Steward O. Evidence that protein constituents of postsynaptic membrane specializations are locally synthesized: analysis of proteins synthesized within synaptosomes. J. Neurosci. 1991, 11(9):2881-2895.
43. Reczko M., Maragkakis M., Alexiou P., Grosse I., Hatzigeorgiou A.G. Functional microRNA targets in protein coding sequences. Bioinformatics 2012, 28(6):771-776.
44. Risbud R.M., Porter B.E. Changes in microRNA expression in the whole hippocampus and hippocampal synaptoneurosome fraction following pilocarpine induced status epilepticus. PLoS One 2013, 8(1):e53464.
45. Rodriguez-Lebron E., Liu G., Keiser M., Behlke M.A., Davidson B.L. Altered Purkinje cell miRNA expression and SCA1 pathogenesis. Neurobiol. Dis. 2013, 54:456-463.
46. Saba R., Goodman C.D., Huzarewich R.L., Robertson C., Booth S.A. A miRNA signature of prion induced neurodegeneration. PLoS One 2008, 3(11):e3652.
47. Saba R., et al. Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons. Mol. Cell. Biol. 2012, 32(3):619-632.
48. Saba R., et al. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One 2012, 7(2):e30832.
49. Scheff S.W., Price D.A. Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. J. Alzheimers Dis. 2006, 9(3 Suppl.):101-115.
50. Scheff S.W., Price D.A., Schmitt F.A., DeKosky S.T., Mufson E.J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007, 68(18):1501-1508.
51. Siegel G., Saba R., Schratt G. microRNAs in neurons: manifold regulatory roles at the synapse. Curr. Opin. Genet. Dev. 2011, 21(4):491-497.
52. Siskova Z., Page A., O'Connor V., Perry V.H. Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping. Am. J. Pathol. 2009, 175(4):1610-1621.
53. Storchel P.H., et al. A large-scale functional screen identifies Nova1 and Ncoa3 as regulators of neuronal miRNA function. EMBO J. 2015, 34(17):2237-2254.
54. Sun T.Y., et al. Expression profiling of microRNAs in hippocampus of rats following traumatic brain injury. J. Huazhong Univ. Sci. Technol. Med. Sci. 2014, 34(4):548-553.
55. Szafranski K., Abraham K.J., Mekhail K. Non-coding RNA in neural function, disease, and aging. Front. Genet. 2015, 6:87.
56. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(33):12481-12486.
57. Tortosa E., et al. Microtubule-associated protein 1B (MAP1B) is required for dendritic spine development and synaptic maturation. J. Biol. Chem. 2011, 286(47):40638-40648.
58. Truettner J.S., Alonso O.F., Bramlett H.M., Dietrich W.D. Therapeutic hypothermia alters microRNA responses to traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 2011, 31(9):1897-1907.
59. Wang W.X., et al. Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injury. Exp. Neurol. 2015, 265:84-93.
60. Wibrand K., et al. MicroRNA regulation of the synaptic plasticity-related gene arc. PLoS One 2012, 7(7):e41688.
61. Zovoilis A., et al. MicroRNA-34c is a novel target to treat dementias. EMBO J. 2011, 30(20):4299-4308.